Overview:

The University of Michigan is one of the largest and broadest based Transplant Centers in the country, performing more than 400 solid organ transplants yearly. Furthermore, over 200 adult and pediatric stem cell transplants (bone marrow transplants) are performed annually. While patient outcomes are generally excellent, many of these patients have to take medications to prevent rejection of their transplanted organ or to prevent “graft versus host disease.” This suppression of the immune system makes organ and bone marrow transplant recipients susceptible to a variety of infections. The transplant infectious disease service works closely with the transplant surgeons and many other medical specialists involved in the care of these complex patients to both treat and prevent infections.